PPAR Research

简称 PPAR RES ·UNITED STATES ·年均收录 34 篇

3.1

最新影响因子

10.10%

自引率

约25%

投稿难度

平均12月

审稿周期

期刊简介

PPAR Research是一本专注于过氧化物酶体增殖物激活受体（PPAR）相关研究的国际学术期刊，其ISSN号为1687-4757，由美国Hindawi出版社出版，出版地为美国，出版周期为年刊。该杂志是开放获取（OA）期刊，曾被SCI收录，但需注意其当前的SCI收录状态可能发生变化，中科院分区情况需根据最新年度分区表确认。杂志的发文特点集中于PPAR在代谢性疾病、炎症、癌症等领域的分子机制、药理作用及临床研究，涵盖基础与转化医学内容。其质量因出版商Hindawi曾存在部分争议需谨慎，近年来因开放获取政策可能吸引较多投稿，但需关注论文审稿标准和学术声誉的潜在风险，建议投稿前核实最新影响因子及索引收录状态。

影响因子趋势

近期发表

Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?” 2026-07-02

10.1155/ppar.v2026.1 2026-01-29

The Mechanistic Role of PPAR γ in Wound Healing 2026-01-29

Diabetic Corneal Neuropathy: Pathogenic Mechanisms and the Emerging Role of PPARs 2026-03-13

Correction to “Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia–Reperfusion Injury by Modulating JAK2/STAT3 β /PPAR α Pathway” 2026-01-31

Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches 2026-05-09

RETRACTION: Synergistic Antiproliferative Effects of Combined γ ‐Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ ‐Independent Mechanisms in Breast Cancer Cells 2026-07-14

Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis 2026-06-22

Mediating Role of Muscle Mass in the Relationship Between Physical Activity and Bone Mass in Female University Students in China 2026-04-04

To Explore the Active Components, Targets, and Potential Effects of Emodin in the Treatment of Colorectal Cancer Based on Network Pharmacology 2025-11-12